Linkang Cai
Wuhan, 436000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Preparation and antitumor activity characterization of oncolytic nanoparticles encapsulating CVA21
Journal: Sheng wu gong cheng xue bao = Chinese journal of biotechnology
Published: May 06, 2025
Development and application of an uncapped mRNA platform.
Journal: Annals of medicine
Published: December 09, 2024
Preclinical safety assessment of an oncolytic herpes simplex virus type 2 expressed PD-L1/CD3 bispecific antibody.
Journal: International immunopharmacology
Published: July 18, 2023
Immune-check blocking combination multiple cytokines shown curative potential in mice tumor model.
Journal: Cancer medicine
Published: November 09, 2022
Transarterial viroembolization improves the therapeutic efficacy of immune-excluded liver cancer: Three birds with one stone.
Journal: Pharmacological research
Published: September 24, 2022
Bispecific Antibody Expressed by an Oncolytic Herpes Simplex Virus Type 2 Can Transform Heterologous T Cells Into Uniform Tumor Killer Cells.
Journal: Human gene therapy
Published: March 11, 2022
BGC823 Cell Line with the Stable Expression of iRFP720 Retains Its Primary Properties with Promising Fluorescence Imaging Ability.
Journal: DNA and cell biology
Published: February 26, 2020
The construction of a new oncolytic herpes simplex virus expressing murine interleukin-15 with gene-editing technology.
Journal: Journal of medical virology
Published: March 07, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026